董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Gareth Sheridan | 男 | Chief Executive Officer and Director | 36 | 35.84万美元 | 未持股 | 2026-01-24 |
| Serguei Melnik | 男 | Chairman of the Board, President and Secretary | 53 | 35.84万美元 | 未持股 | 2026-01-24 |
| Radu Bujoreanu | 男 | Director | 56 | 6.04万美元 | 未持股 | 2026-01-24 |
| Mark Hamilton | 男 | Independent Director | 41 | 6.47万美元 | 未持股 | 2026-01-24 |
| Stefani Mancas | 女 | Director | 49 | 5.41万美元 | 未持股 | 2026-01-24 |
| Irina Gram | 女 | Director | 38 | 0.50万美元 | 未持股 | 2026-01-24 |
| Sergei Glinka | 男 | Director | 59 | 未披露 | 未持股 | 2026-01-24 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Gareth Sheridan | 男 | Chief Executive Officer and Director | 36 | 35.84万美元 | 未持股 | 2026-01-24 |
| Serguei Melnik | 男 | Chairman of the Board, President and Secretary | 53 | 35.84万美元 | 未持股 | 2026-01-24 |
| Gerald Goodman | 男 | Chief Accounting Officer and Chief Financial Officer | 77 | 26.26万美元 | 未持股 | 2026-01-24 |
| Alan Smith | 男 | Chief Operating Officer and President of 4P Therapeutics | 60 | 30.10万美元 | 未持股 | 2026-01-24 |
| Jeff Patrick | 男 | Chief Scientific Officer | 56 | 未披露 | 未持股 | 2026-01-24 |
董事简历
中英对照 | 中文 | 英文- Gareth Sheridan
-
Gareth Sheridan自2016年以来一直担任本组织的首席执行官兼董事。Sheridan先生于2012年创立了Nutriband Ltd.，这是一家爱尔兰公司，我们于2016年收购了该公司。Sheridan先生于2014年因建立Nutriband Ltd.而被爱尔兰国家银行（National Bank of Ireland）授予“年度青年企业家奖”。Sheridan先生还获得了S.Dublin&8217；最佳青年企业家和Nutriband Ltd颁发的S.Dublin&8217；最佳创业公司的商业奖项。谢里丹也是日产过去一代的下一代大使，2015年，他被日产爱尔兰公司（Nissan Ireland）评为爱尔兰未来几代领导人之一。Sheridan先生获得了理学学士学位。他于2012年获得Dublin Institute of Technology的商业和管理学位，在那里他专注于国际经济、风险创造和创业。
Gareth Sheridan , Nutriband Inc. founder, has been chief executive officer and a director since Nutriband Inc. organization in 2016. In 2012, Mr. Sheridan founded Nutriband Ltd., an Irish company which acquired in 2016. Mr. Sheridan was named Ireland's 'Young Entrepreneur of the Year' in 2014 in the National Bank of Ireland Startup Awards for establishing Nutriband Ltd. Mr. Sheridan has further business awards from S. Dublin's Best Young Entrepreneur and Nutriband Ltd as S. Dublin's Best Startup Company. Mr. Sheridan has also worked as a Business Mentor with 100 Minds, a social enterprise founded in 2013, that brings together some of Ireland's top college students and connects them with one cause to achieve large charitable goals in a short space o time. Mr. Sheridan is also a past Nissan Generation Next Ambassador, receiving the acknowledgement in 2015 by Nissan Ireland as one of Ireland's future generational leaders.In 2019 Mr. Sheridan served on the Board of the St. James Hospital foundation, the charitable foundation for Ireland's largest public hospital. Mr. Sheridan received a B.Sc. in Business and Management from Dublin Institute of Technology in 2012 where he concentrated on international economics, venture creation and entrepreneurship. - Gareth Sheridan自2016年以来一直担任本组织的首席执行官兼董事。Sheridan先生于2012年创立了Nutriband Ltd.，这是一家爱尔兰公司，我们于2016年收购了该公司。Sheridan先生于2014年因建立Nutriband Ltd.而被爱尔兰国家银行（National Bank of Ireland）授予“年度青年企业家奖”。Sheridan先生还获得了S.Dublin&8217；最佳青年企业家和Nutriband Ltd颁发的S.Dublin&8217；最佳创业公司的商业奖项。谢里丹也是日产过去一代的下一代大使，2015年，他被日产爱尔兰公司（Nissan Ireland）评为爱尔兰未来几代领导人之一。Sheridan先生获得了理学学士学位。他于2012年获得Dublin Institute of Technology的商业和管理学位，在那里他专注于国际经济、风险创造和创业。
- Gareth Sheridan , Nutriband Inc. founder, has been chief executive officer and a director since Nutriband Inc. organization in 2016. In 2012, Mr. Sheridan founded Nutriband Ltd., an Irish company which acquired in 2016. Mr. Sheridan was named Ireland's 'Young Entrepreneur of the Year' in 2014 in the National Bank of Ireland Startup Awards for establishing Nutriband Ltd. Mr. Sheridan has further business awards from S. Dublin's Best Young Entrepreneur and Nutriband Ltd as S. Dublin's Best Startup Company. Mr. Sheridan has also worked as a Business Mentor with 100 Minds, a social enterprise founded in 2013, that brings together some of Ireland's top college students and connects them with one cause to achieve large charitable goals in a short space o time. Mr. Sheridan is also a past Nissan Generation Next Ambassador, receiving the acknowledgement in 2015 by Nissan Ireland as one of Ireland's future generational leaders.In 2019 Mr. Sheridan served on the Board of the St. James Hospital foundation, the charitable foundation for Ireland's largest public hospital. Mr. Sheridan received a B.Sc. in Business and Management from Dublin Institute of Technology in 2012 where he concentrated on international economics, venture creation and entrepreneurship.
- Serguei Melnik
-
Serguei Melnik自2016年1月以来一直担任我们的首席财务官和董事。Melnik先生一直参与美国金融市场公司的一般业务咨询，并为外国公司在美国的运营建立法律和财务框架。通过他的咨询公司Wolf Blitz Inc.与厄瓜多尔、乌克兰、摩尔多瓦和罗马尼亚的客户就多个国际贸易交易进行咨询。Melnik先生在摩尔多瓦国立大学（Moldova State University）获得法律学位。
Serguei Melnik , who was elected by the Board as President on October 8, 2021, serves as a member of the board of directors and is a co-founder of Nutriband Inc. Mr. Melnik has previously served as Nutriband Inc. chief financial officer and a director since January 2016. Mr. Melnik has been involved in general business consulting for companies in the U.S. financial markets and setting up a legal and financial framework for operations of foreign companies in the U.S. Mr. Melnik advised UNR Holdings, Inc. with regard to the initiation of the trading of its stock in the over-the-counter markets in the U.S. and has provided general advice with respect to the U.S. financial markets for companies located in the U.S. and abroad. From February 2003 to May 2005, he was the Chief Operations Officer and a Board member of Asconi Corporation, Winter Park, Florida, with regard to restructuring the company and listing it on the American Stock Exchange. Mr. Melnik from June 1995 to December 1996 was a lawyer in the Department of Foreign Affairs, JSC Bank "Inteprinzbanca,", Chisinau, Moldova, and prior thereto practiced law in Moldova in various positions. Mr. Melnik is fluent in Russian, Romanian, English and Spanish. - Serguei Melnik自2016年1月以来一直担任我们的首席财务官和董事。Melnik先生一直参与美国金融市场公司的一般业务咨询，并为外国公司在美国的运营建立法律和财务框架。通过他的咨询公司Wolf Blitz Inc.与厄瓜多尔、乌克兰、摩尔多瓦和罗马尼亚的客户就多个国际贸易交易进行咨询。Melnik先生在摩尔多瓦国立大学（Moldova State University）获得法律学位。
- Serguei Melnik , who was elected by the Board as President on October 8, 2021, serves as a member of the board of directors and is a co-founder of Nutriband Inc. Mr. Melnik has previously served as Nutriband Inc. chief financial officer and a director since January 2016. Mr. Melnik has been involved in general business consulting for companies in the U.S. financial markets and setting up a legal and financial framework for operations of foreign companies in the U.S. Mr. Melnik advised UNR Holdings, Inc. with regard to the initiation of the trading of its stock in the over-the-counter markets in the U.S. and has provided general advice with respect to the U.S. financial markets for companies located in the U.S. and abroad. From February 2003 to May 2005, he was the Chief Operations Officer and a Board member of Asconi Corporation, Winter Park, Florida, with regard to restructuring the company and listing it on the American Stock Exchange. Mr. Melnik from June 1995 to December 1996 was a lawyer in the Department of Foreign Affairs, JSC Bank "Inteprinzbanca,", Chisinau, Moldova, and prior thereto practiced law in Moldova in various positions. Mr. Melnik is fluent in Russian, Romanian, English and Spanish.
- Radu Bujoreanu
-
Radu Bujoreanu自2019年6月起担任董事。Bujoreanu先生自2002年12月以来一直是领事协助有限公司的所有者兼执行董事，该公司为莫尔达瓦共和国提供签证和相关服务方面的协助，他自2019年5月以来一直是Keller Williams Realty，Inc.的房地产经纪人。Bujoreanu先生在摩尔多瓦大学（University of Moldova）获得国际公法学士学位。
Radu Bujoreanu has been a director since June 2019. Mr. Bujoreanu is a real estate agent and investor since 2019 and currently he is with Samson Properties LLC. Mr. Bujoreanu has been the owner and executive director of Consular Assistance, Inc., which provided assistance in obtaining visas, travel documents, other national and foreign documents and related services from December 2002 to December 2020. From 2003 to 2005 he served as an independent director and member of the Board of Directors of Asconi Corporation. From Augt 1999 to Augt 2002 Mr. ujoreanu worked as a consular officer at the Embassy of the Republic of Moldova to the United States. Before that from May 1994 to Augt 1999 he was Chief of Bilateral Treaties section in the International Law and Treaties Department of the Ministry of Foreign Affairs of the Republic of Moldova. Mr. Bujoreanu received a bachelor's degree in international public law from the University of Moldova. - Radu Bujoreanu自2019年6月起担任董事。Bujoreanu先生自2002年12月以来一直是领事协助有限公司的所有者兼执行董事，该公司为莫尔达瓦共和国提供签证和相关服务方面的协助，他自2019年5月以来一直是Keller Williams Realty，Inc.的房地产经纪人。Bujoreanu先生在摩尔多瓦大学（University of Moldova）获得国际公法学士学位。
- Radu Bujoreanu has been a director since June 2019. Mr. Bujoreanu is a real estate agent and investor since 2019 and currently he is with Samson Properties LLC. Mr. Bujoreanu has been the owner and executive director of Consular Assistance, Inc., which provided assistance in obtaining visas, travel documents, other national and foreign documents and related services from December 2002 to December 2020. From 2003 to 2005 he served as an independent director and member of the Board of Directors of Asconi Corporation. From Augt 1999 to Augt 2002 Mr. ujoreanu worked as a consular officer at the Embassy of the Republic of Moldova to the United States. Before that from May 1994 to Augt 1999 he was Chief of Bilateral Treaties section in the International Law and Treaties Department of the Ministry of Foreign Affairs of the Republic of Moldova. Mr. Bujoreanu received a bachelor's degree in international public law from the University of Moldova.
- Mark Hamilton
-
Mark Hamilton在BDO Ireland（一家主要的会计公司）工作了9年多，担任过公司财务、公司咨询、重组和恢复、客户管理以及目前在业务发展方面的职务。Hamilton先生是一名特许会计师，自2012年以来甚至是特许会计师协会的成员。Hamilton先生获得了理学学士学位。他于2008年获得Dublin Institute of Technology的商业和管理学士学位，随后于2009年获得会计专业研究生学位的一级荣誉。
Mark Hamilton is an experienced director level professional who joined global consulting firm, Korn Ferry, in 2020 as a Managing Consultant. Prior to moving into organizational consulting, Mark qualified as a Chartered Accountant in global advisory firm, BDO, where he spent 12 years advising some of Ireland's most successful binesses. His work originated in corporate finance/corporate recovery and more recently, he spent 5 years leading BDO's client management and sales function, as Head of Biness Development.Mr. Hamilton is a Member of the Association of Chartered Accountants (ACA), since 2012. Mr. Hamilton's accounting/consulting background and experience in corporate finance, restructuring, sales and talent assists in his role as an independent Board member and Committee Chair. Mr. Hamilton has a very strong presence in the biness community across jurisdictions, along with an accomplished track record in project management and biness development. Educated at Terenure College, Mark nt on to study a B.Sc. degree in Biness & Management at Dublin Institute of Technology and subsequently received First Class Hons in his postgraduate degree, for which he specialized in Accountancy in 2009. - Mark Hamilton在BDO Ireland（一家主要的会计公司）工作了9年多，担任过公司财务、公司咨询、重组和恢复、客户管理以及目前在业务发展方面的职务。Hamilton先生是一名特许会计师，自2012年以来甚至是特许会计师协会的成员。Hamilton先生获得了理学学士学位。他于2008年获得Dublin Institute of Technology的商业和管理学士学位，随后于2009年获得会计专业研究生学位的一级荣誉。
- Mark Hamilton is an experienced director level professional who joined global consulting firm, Korn Ferry, in 2020 as a Managing Consultant. Prior to moving into organizational consulting, Mark qualified as a Chartered Accountant in global advisory firm, BDO, where he spent 12 years advising some of Ireland's most successful binesses. His work originated in corporate finance/corporate recovery and more recently, he spent 5 years leading BDO's client management and sales function, as Head of Biness Development.Mr. Hamilton is a Member of the Association of Chartered Accountants (ACA), since 2012. Mr. Hamilton's accounting/consulting background and experience in corporate finance, restructuring, sales and talent assists in his role as an independent Board member and Committee Chair. Mr. Hamilton has a very strong presence in the biness community across jurisdictions, along with an accomplished track record in project management and biness development. Educated at Terenure College, Mark nt on to study a B.Sc. degree in Biness & Management at Dublin Institute of Technology and subsequently received First Class Hons in his postgraduate degree, for which he specialized in Accountancy in 2009.
- Stefani Mancas
-
2007年5月，Stefan Mancas在Roy S.Choudhury博士的指导下获得中佛罗里达大学应用数学博士学位，他的论文题目是三次五次复Ginzburg Landau方程中的耗散孤子:分岔与时空结构，2008年因此获得杰出论文奖。Mancas博士是Embry-Riddle航空大学数学系的教授和副教授。他是非线性波浪实验室的联合创始人，该实验室包含一个10米长的水箱，用于研究水波、浅海中的孤子、涡旋孤子、孤子船、表面波和风波相互作用、微空化、设计和优化、海底水流、自主水下航行器、拖拉机梁等。他也是应用数学国家和国际会议的组织者，并在参考期刊上发表了40多篇文章。
Stefani Mancas graduated Summa cum Laude from the Military Navy College in Constanta, Romania. After attending the faculty of Cybernetics from the Academy of Economic Studies in Bucharest, Stefani transferred to University of Central Florida, and graduated with a dual B.Sc. in Mathematics/Aerospace Engineering, a master's degree in applied mathematics, and a Ph.D. in mathematical sciences from the Department of Mathematics. The Ph.D. dissertation topic was "Dissipative solitons in the cubic quintic complex Ginzburg Landau equation: Bifurcations and Spatiotemporal Structure", for which Stefani received the UCF Outstanding Dissertation Award.Currently, Stefani is a tenured full Professor, and a researcher in the Department of Mathematics at Embry Riddle Aeronautical University in Daytona Beach, Florida. Stefani's research areas deal with finding analytical solutions to nonlinear dissipative equations that can be reduced through Darboux transformations to Riccati or Abel equations. The main foc is on Schrdinger equation, for which Stefani is ing methods based on factorization, and variational formulation together with ansatz reduction with global minimizers of objective functions, applied to supersymmetric quantum mechanics. Another important area of interest is the theory of elliptic functions with applications to nonlinear optics, soliton theory, general relativity, as ll as optimization of the blockchain, and quantum cryptography. - 2007年5月，Stefan Mancas在Roy S.Choudhury博士的指导下获得中佛罗里达大学应用数学博士学位，他的论文题目是三次五次复Ginzburg Landau方程中的耗散孤子:分岔与时空结构，2008年因此获得杰出论文奖。Mancas博士是Embry-Riddle航空大学数学系的教授和副教授。他是非线性波浪实验室的联合创始人，该实验室包含一个10米长的水箱，用于研究水波、浅海中的孤子、涡旋孤子、孤子船、表面波和风波相互作用、微空化、设计和优化、海底水流、自主水下航行器、拖拉机梁等。他也是应用数学国家和国际会议的组织者，并在参考期刊上发表了40多篇文章。
- Stefani Mancas graduated Summa cum Laude from the Military Navy College in Constanta, Romania. After attending the faculty of Cybernetics from the Academy of Economic Studies in Bucharest, Stefani transferred to University of Central Florida, and graduated with a dual B.Sc. in Mathematics/Aerospace Engineering, a master's degree in applied mathematics, and a Ph.D. in mathematical sciences from the Department of Mathematics. The Ph.D. dissertation topic was "Dissipative solitons in the cubic quintic complex Ginzburg Landau equation: Bifurcations and Spatiotemporal Structure", for which Stefani received the UCF Outstanding Dissertation Award.Currently, Stefani is a tenured full Professor, and a researcher in the Department of Mathematics at Embry Riddle Aeronautical University in Daytona Beach, Florida. Stefani's research areas deal with finding analytical solutions to nonlinear dissipative equations that can be reduced through Darboux transformations to Riccati or Abel equations. The main foc is on Schrdinger equation, for which Stefani is ing methods based on factorization, and variational formulation together with ansatz reduction with global minimizers of objective functions, applied to supersymmetric quantum mechanics. Another important area of interest is the theory of elliptic functions with applications to nonlinear optics, soliton theory, general relativity, as ll as optimization of the blockchain, and quantum cryptography.
- Irina Gram
-
Irina Gram在2022年1月21日的股东大会上被选为公司董事。Irina是Nutriband Inc.董事会的新成员，同时也是佛罗里达州墨尔本Thales IFEC的高级金融分析师。在那里，她负责多个开发和客户项目的财务规划、分析以及风险和机会审查。2016年至2017年，她在泰雷兹IFEC担任项目工程协调员，负责执行预算编制和预测活动，专门关注SFRD支出，并与工程团队互动，监测和报告项目财务影响的绩效。2013年至2016年，她在佛罗里达州温特帕克的Siemens Building Technology，Inc.担任多个项目管理、会计和报告职位。她于2015年5月以优异成绩毕业于佛罗里达州奥兰多市中佛罗里达大学，获得金融学学士学位，并于2019年5月在佛罗里达州奥兰多市中佛罗里达大学获得工商管理硕士学位。
Irina Gram is a Senior Financial Analyst at Thales IFEC, Melbne, Florida. There she is responsible for financial planning, analysis and risk and opportunities reviews of multiple development and ctomer programs. From 2016 to 2017, she was a Project Engineering Coordinator at Thales IFEC, where she executed budgeting and forecasting activities with a specialized foc on SFRD spending, interfaced with engineering team to monitor and report the performance of the financial impact of projects. - Irina Gram在2022年1月21日的股东大会上被选为公司董事。Irina是Nutriband Inc.董事会的新成员，同时也是佛罗里达州墨尔本Thales IFEC的高级金融分析师。在那里，她负责多个开发和客户项目的财务规划、分析以及风险和机会审查。2016年至2017年，她在泰雷兹IFEC担任项目工程协调员，负责执行预算编制和预测活动，专门关注SFRD支出，并与工程团队互动，监测和报告项目财务影响的绩效。2013年至2016年，她在佛罗里达州温特帕克的Siemens Building Technology，Inc.担任多个项目管理、会计和报告职位。她于2015年5月以优异成绩毕业于佛罗里达州奥兰多市中佛罗里达大学，获得金融学学士学位，并于2019年5月在佛罗里达州奥兰多市中佛罗里达大学获得工商管理硕士学位。
- Irina Gram is a Senior Financial Analyst at Thales IFEC, Melbne, Florida. There she is responsible for financial planning, analysis and risk and opportunities reviews of multiple development and ctomer programs. From 2016 to 2017, she was a Project Engineering Coordinator at Thales IFEC, where she executed budgeting and forecasting activities with a specialized foc on SFRD spending, interfaced with engineering team to monitor and report the performance of the financial impact of projects.
- Sergei Glinka
-
Sergei Glinka自2019年起担任TG Biochemicals Limited，CYPR的商务经理。自2019年以来，他一直是爱沙尼亚GST Investments O ü的股东和董事会成员。从2000年到2019年，Glinka先生是Transgroup Invest AS的股东和董事会成员。格林卡先生于1973年开始在摩尔多瓦上中学，1981年毕业，1986年毕业于爱沙尼亚塔林商船学校。
Sergei Glinka has been the Commercial Manager of TG Biochemicals Limited, Cypr, since 2019. He has been a shareholder and member of the Board of GST Investments O, Estonia since 2019. From 2000 to 2019, Mr. Glinka was a shareholder and member of the Board of Transgroup Invest AS. Commencing in 1973 Mr. Glinka attended secondary school in Moldova, graduating in 1981, and graduated from the Tallinn Merchant Marine School, Estonia, in 1986. - Sergei Glinka自2019年起担任TG Biochemicals Limited，CYPR的商务经理。自2019年以来，他一直是爱沙尼亚GST Investments O ü的股东和董事会成员。从2000年到2019年，Glinka先生是Transgroup Invest AS的股东和董事会成员。格林卡先生于1973年开始在摩尔多瓦上中学，1981年毕业，1986年毕业于爱沙尼亚塔林商船学校。
- Sergei Glinka has been the Commercial Manager of TG Biochemicals Limited, Cypr, since 2019. He has been a shareholder and member of the Board of GST Investments O, Estonia since 2019. From 2000 to 2019, Mr. Glinka was a shareholder and member of the Board of Transgroup Invest AS. Commencing in 1973 Mr. Glinka attended secondary school in Moldova, graduating in 1981, and graduated from the Tallinn Merchant Marine School, Estonia, in 1986.
高管简历
中英对照 | 中文 | 英文- Gareth Sheridan
Gareth Sheridan自2016年以来一直担任本组织的首席执行官兼董事。Sheridan先生于2012年创立了Nutriband Ltd.，这是一家爱尔兰公司，我们于2016年收购了该公司。Sheridan先生于2014年因建立Nutriband Ltd.而被爱尔兰国家银行（National Bank of Ireland）授予“年度青年企业家奖”。Sheridan先生还获得了S.Dublin&8217；最佳青年企业家和Nutriband Ltd颁发的S.Dublin&8217；最佳创业公司的商业奖项。谢里丹也是日产过去一代的下一代大使，2015年，他被日产爱尔兰公司（Nissan Ireland）评为爱尔兰未来几代领导人之一。Sheridan先生获得了理学学士学位。他于2012年获得Dublin Institute of Technology的商业和管理学位，在那里他专注于国际经济、风险创造和创业。
Gareth Sheridan , Nutriband Inc. founder, has been chief executive officer and a director since Nutriband Inc. organization in 2016. In 2012, Mr. Sheridan founded Nutriband Ltd., an Irish company which acquired in 2016. Mr. Sheridan was named Ireland's 'Young Entrepreneur of the Year' in 2014 in the National Bank of Ireland Startup Awards for establishing Nutriband Ltd. Mr. Sheridan has further business awards from S. Dublin's Best Young Entrepreneur and Nutriband Ltd as S. Dublin's Best Startup Company. Mr. Sheridan has also worked as a Business Mentor with 100 Minds, a social enterprise founded in 2013, that brings together some of Ireland's top college students and connects them with one cause to achieve large charitable goals in a short space of time. Mr. Sheridan is also a past Nissan Generation Next Ambassador, receiving the acknowledgement in 2015 by Nissan Ireland as one of Ireland's future generational leaders.In 2019 Mr. Sheridan served on the Board of the St. James Hospital foundation, the charitable foundation for Ireland's largest public hospital. Mr. Sheridan received a B.Sc. in Business and Management from Dublin Institute of Technology in 2012 where he concentrated on international economics, venture creation and entrepreneurship.- Gareth Sheridan自2016年以来一直担任本组织的首席执行官兼董事。Sheridan先生于2012年创立了Nutriband Ltd.，这是一家爱尔兰公司，我们于2016年收购了该公司。Sheridan先生于2014年因建立Nutriband Ltd.而被爱尔兰国家银行（National Bank of Ireland）授予“年度青年企业家奖”。Sheridan先生还获得了S.Dublin&8217；最佳青年企业家和Nutriband Ltd颁发的S.Dublin&8217；最佳创业公司的商业奖项。谢里丹也是日产过去一代的下一代大使，2015年，他被日产爱尔兰公司（Nissan Ireland）评为爱尔兰未来几代领导人之一。Sheridan先生获得了理学学士学位。他于2012年获得Dublin Institute of Technology的商业和管理学位，在那里他专注于国际经济、风险创造和创业。
- Gareth Sheridan , Nutriband Inc. founder, has been chief executive officer and a director since Nutriband Inc. organization in 2016. In 2012, Mr. Sheridan founded Nutriband Ltd., an Irish company which acquired in 2016. Mr. Sheridan was named Ireland's 'Young Entrepreneur of the Year' in 2014 in the National Bank of Ireland Startup Awards for establishing Nutriband Ltd. Mr. Sheridan has further business awards from S. Dublin's Best Young Entrepreneur and Nutriband Ltd as S. Dublin's Best Startup Company. Mr. Sheridan has also worked as a Business Mentor with 100 Minds, a social enterprise founded in 2013, that brings together some of Ireland's top college students and connects them with one cause to achieve large charitable goals in a short space of time. Mr. Sheridan is also a past Nissan Generation Next Ambassador, receiving the acknowledgement in 2015 by Nissan Ireland as one of Ireland's future generational leaders.In 2019 Mr. Sheridan served on the Board of the St. James Hospital foundation, the charitable foundation for Ireland's largest public hospital. Mr. Sheridan received a B.Sc. in Business and Management from Dublin Institute of Technology in 2012 where he concentrated on international economics, venture creation and entrepreneurship.
- Serguei Melnik
Serguei Melnik自2016年1月以来一直担任我们的首席财务官和董事。Melnik先生一直参与美国金融市场公司的一般业务咨询，并为外国公司在美国的运营建立法律和财务框架。通过他的咨询公司Wolf Blitz Inc.与厄瓜多尔、乌克兰、摩尔多瓦和罗马尼亚的客户就多个国际贸易交易进行咨询。Melnik先生在摩尔多瓦国立大学（Moldova State University）获得法律学位。
Serguei Melnik , who was elected by the Board as President on October 8, 2021, serves as a member of the board of directors and is a co-founder of Nutriband Inc. Mr. Melnik has previously served as Nutriband Inc. chief financial officer and a director since January 2016. Mr. Melnik has been involved in general business consulting for companies in the U.S. financial markets and setting up a legal and financial framework for operations of foreign companies in the U.S. Mr. Melnik advised UNR Holdings, Inc. with regard to the initiation of the trading of its stock in the over-the-counter markets in the U.S. and has provided general advice with respect to the U.S. financial markets for companies located in the U.S. and abroad. From February 2003 to May 2005, he was the Chief Operations Officer and a Board member of Asconi Corporation, Winter Park, Florida, with regard to restructuring the company and listing it on the American Stock Exchange. Mr. Melnik from June 1995 to December 1996 was a lawyer in the Department of Foreign Affairs, JSC Bank "Inteprinzbanca,", Chisinau, Moldova, and prior thereto practiced law in Moldova in various positions. Mr. Melnik is fluent in Russian, Romanian, English and Spanish.- Serguei Melnik自2016年1月以来一直担任我们的首席财务官和董事。Melnik先生一直参与美国金融市场公司的一般业务咨询，并为外国公司在美国的运营建立法律和财务框架。通过他的咨询公司Wolf Blitz Inc.与厄瓜多尔、乌克兰、摩尔多瓦和罗马尼亚的客户就多个国际贸易交易进行咨询。Melnik先生在摩尔多瓦国立大学（Moldova State University）获得法律学位。
- Serguei Melnik , who was elected by the Board as President on October 8, 2021, serves as a member of the board of directors and is a co-founder of Nutriband Inc. Mr. Melnik has previously served as Nutriband Inc. chief financial officer and a director since January 2016. Mr. Melnik has been involved in general business consulting for companies in the U.S. financial markets and setting up a legal and financial framework for operations of foreign companies in the U.S. Mr. Melnik advised UNR Holdings, Inc. with regard to the initiation of the trading of its stock in the over-the-counter markets in the U.S. and has provided general advice with respect to the U.S. financial markets for companies located in the U.S. and abroad. From February 2003 to May 2005, he was the Chief Operations Officer and a Board member of Asconi Corporation, Winter Park, Florida, with regard to restructuring the company and listing it on the American Stock Exchange. Mr. Melnik from June 1995 to December 1996 was a lawyer in the Department of Foreign Affairs, JSC Bank "Inteprinzbanca,", Chisinau, Moldova, and prior thereto practiced law in Moldova in various positions. Mr. Melnik is fluent in Russian, Romanian, English and Spanish.
- Gerald Goodman
Gerald Goodman自2018年7月31日起担任我们的首席会计官。Goodman先生是一名注册会计师，自2014年起在自己的公司Gerald Goodman CPA P.C.执业。从2010年1月1日至2014年12月31日，Goodman先生在犹他州默里的Madsen&Associates，CPA&8217；S Inc.执业，是非股权合伙人，并管理该公司的SEC业务。Goodman先生是Lifestyle Medical Network，Inc.的董事，该公司为梦百合供应商提供管理服务。从1971年到2010年，Goodman先生是Wiener，Goodman&Company P.C.会计师事务所的合伙人。他是宾夕法尼亚州立大学（Pennsylvania State University）的1970年毕业生，在那里他获得会计学士学位。Goodman先生为我们兼职工作。
Gerald Goodman has been Nutriband Inc. chief accounting officer since July 3, 2018 and was elected Nutriband Inc. Chief Financial Officer on November 12, 2020. Mr. Goodman is a certified public accountant and, since 2014, has practiced with his own firm, Gerald Goodman CPA P.C. From January 1, 2010 until December 31, 2014, Mr. Goodman practiced with Madsen & Associates, CPA's Inc., Murray, Utah, and was a non-equity partner and managed the firm's SEC practice. Mr. Goodman is a director of Lifestyle Medical Network, Inc., which provides management services to healthcare providers. From 1971 to 2010, Mr. Goodman was a partner in the accounting firm of Wiener, Goodman & Company P.C. Mr. Goodman is a 1970 graduate of Pennsylvania State University where he received a B.S. Degree in Accounting.- Gerald Goodman自2018年7月31日起担任我们的首席会计官。Goodman先生是一名注册会计师，自2014年起在自己的公司Gerald Goodman CPA P.C.执业。从2010年1月1日至2014年12月31日，Goodman先生在犹他州默里的Madsen&Associates，CPA&8217；S Inc.执业，是非股权合伙人，并管理该公司的SEC业务。Goodman先生是Lifestyle Medical Network，Inc.的董事，该公司为梦百合供应商提供管理服务。从1971年到2010年，Goodman先生是Wiener，Goodman&Company P.C.会计师事务所的合伙人。他是宾夕法尼亚州立大学（Pennsylvania State University）的1970年毕业生，在那里他获得会计学士学位。Goodman先生为我们兼职工作。
- Gerald Goodman has been Nutriband Inc. chief accounting officer since July 3, 2018 and was elected Nutriband Inc. Chief Financial Officer on November 12, 2020. Mr. Goodman is a certified public accountant and, since 2014, has practiced with his own firm, Gerald Goodman CPA P.C. From January 1, 2010 until December 31, 2014, Mr. Goodman practiced with Madsen & Associates, CPA's Inc., Murray, Utah, and was a non-equity partner and managed the firm's SEC practice. Mr. Goodman is a director of Lifestyle Medical Network, Inc., which provides management services to healthcare providers. From 1971 to 2010, Mr. Goodman was a partner in the accounting firm of Wiener, Goodman & Company P.C. Mr. Goodman is a 1970 graduate of Pennsylvania State University where he received a B.S. Degree in Accounting.
- Alan Smith
Alan Smith自2018年12月起担任4P Therapeutics的首席运营官兼总裁。自2018年4月我们签署收购4P Therapeutics的协议以来，他担任我们的Vice President，临床，监管，质量和运营。Smith博士于2011年联合创立了4P Therapeutics。Smith从2000年到2011年在Altea Therapeutics任职，最近担任Vice President、产品开发以及临床研究与开发、监管事务和项目管理主管。在加入Altea Therapeutics公司之前，他曾领导SpectRx公司（一家公开上市的非侵入性诊断公司）的透皮葡萄糖监测系统的开发。在加入Altea Therapeutics公司之前，他曾领导Eli Lilly公司、Amylin公司、Hospira公司、Elan公司和Novartis公司等制药公司的主要研究与开发项目。Smith博士在罗格斯大学（Rutgers University）和新泽西医学和牙科大学（University of Medicine and Dentistry of New Jersey）获得生物医学工程博士学位和硕士学位。他目前任职于The Journal Expert Opinion on Drug Delivery的编辑顾问委员会。
Alan Smith , Ph.D., serves as Chief Operating Officer of Nutriband and President of 4P Therapeutics, a wholly owned subsidiary of Nutriband. He joined the Company after Nutriband acquired 4P Therapeutics in 2018. Dr. Smith co-founded 4P Therapeutics in 2011 to develop drug-device and biologic-device combination products to meet the needs of patients, physicians, and payers, and was Vice President, Clinical, Regulatory, Quality and Operations at the time of the acquisition. Dr. Smith is co-inventor of the Company's Aversa abuse deterrent transdermal system technology. Dr. Smith has over 20 years of experience in the research and development of drug and biologic delivery systems, diagnostics and medical devices for treatment and management of chronic pain, diabetes, and cardiovascular disease. Previously, he was with Altea Therapeutics, a venture capital funded company focused on novel transdermal drug and biologic delivery, most recently serving as Vice President, Product Development and Head of Clinical R&D, Regulatory Affairs, and Project Management. Prior to joining Altea Therapeutics, he led the development of transdermal glucose monitoring systems at SpectRx, Inc., a publicly traded noninvasive diagnostics company. Dr. Smith received Ph.D. and M.S. degrees in Biomedical Engineering from Rutgers University and the University of Medicine and Dentistry of New Jersey. He currently serves on the Editorial Advisory Board of Expert Opinion on Drug Delivery.- Alan Smith自2018年12月起担任4P Therapeutics的首席运营官兼总裁。自2018年4月我们签署收购4P Therapeutics的协议以来，他担任我们的Vice President，临床，监管，质量和运营。Smith博士于2011年联合创立了4P Therapeutics。Smith从2000年到2011年在Altea Therapeutics任职，最近担任Vice President、产品开发以及临床研究与开发、监管事务和项目管理主管。在加入Altea Therapeutics公司之前，他曾领导SpectRx公司（一家公开上市的非侵入性诊断公司）的透皮葡萄糖监测系统的开发。在加入Altea Therapeutics公司之前，他曾领导Eli Lilly公司、Amylin公司、Hospira公司、Elan公司和Novartis公司等制药公司的主要研究与开发项目。Smith博士在罗格斯大学（Rutgers University）和新泽西医学和牙科大学（University of Medicine and Dentistry of New Jersey）获得生物医学工程博士学位和硕士学位。他目前任职于The Journal Expert Opinion on Drug Delivery的编辑顾问委员会。
- Alan Smith , Ph.D., serves as Chief Operating Officer of Nutriband and President of 4P Therapeutics, a wholly owned subsidiary of Nutriband. He joined the Company after Nutriband acquired 4P Therapeutics in 2018. Dr. Smith co-founded 4P Therapeutics in 2011 to develop drug-device and biologic-device combination products to meet the needs of patients, physicians, and payers, and was Vice President, Clinical, Regulatory, Quality and Operations at the time of the acquisition. Dr. Smith is co-inventor of the Company's Aversa abuse deterrent transdermal system technology. Dr. Smith has over 20 years of experience in the research and development of drug and biologic delivery systems, diagnostics and medical devices for treatment and management of chronic pain, diabetes, and cardiovascular disease. Previously, he was with Altea Therapeutics, a venture capital funded company focused on novel transdermal drug and biologic delivery, most recently serving as Vice President, Product Development and Head of Clinical R&D, Regulatory Affairs, and Project Management. Prior to joining Altea Therapeutics, he led the development of transdermal glucose monitoring systems at SpectRx, Inc., a publicly traded noninvasive diagnostics company. Dr. Smith received Ph.D. and M.S. degrees in Biomedical Engineering from Rutgers University and the University of Medicine and Dentistry of New Jersey. He currently serves on the Editorial Advisory Board of Expert Opinion on Drug Delivery.
- Jeff Patrick
Jeff Patrick自2018年5月以来一直担任我们的首席科学官。他也是我们的科学顾问委员会的负责人。Patrick博士自2017年2月起担任俄亥俄州立大学综合癌症中心药物开发研究所所长。Patrick博士于2014年10月至2017年2月担任专业制药公司New Haven Pharmaceuticals，Inc.的首席科学官，Patrick博士于2010年4月至2014年8月担任Mallinckrodt Pharmaceuticals，Inc.的专业事务全球Vice President。帕特里克博士获得了学士学位和药学博士学位。the University of Tennessee学位。Patrick博士还完成了Wharton School of Business Pharmaceutical Executive Program。Patrick博士只将一部分时间用于我们的业务。Patrick博士为我们兼职工作。
Jeff Patrick serves as Director of Drug Development Institute at the Ohio State University Comprehensive Cancer Center. Dr. Patrick most recently serving as Chief Scientific Officer for New Haven Pharmaceuticals. Prior roles included global vice president of professional affairs at Mallinckrodt Pharmaceuticals, Inc.; and roles with ascending responsibilities at Dyax, Myogen/Gilead, Actelion and Sanofi Synthelabo, Inc. Dr. Patrick is a residency trained clinical pharmacist with approximately 20 years of pharmaceutical indtry experience. Prior to pursuing a career in research and development, Patrick was an ambulatory care clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy, where he earned his doctorate in pharmacy.- Jeff Patrick自2018年5月以来一直担任我们的首席科学官。他也是我们的科学顾问委员会的负责人。Patrick博士自2017年2月起担任俄亥俄州立大学综合癌症中心药物开发研究所所长。Patrick博士于2014年10月至2017年2月担任专业制药公司New Haven Pharmaceuticals，Inc.的首席科学官，Patrick博士于2010年4月至2014年8月担任Mallinckrodt Pharmaceuticals，Inc.的专业事务全球Vice President。帕特里克博士获得了学士学位和药学博士学位。the University of Tennessee学位。Patrick博士还完成了Wharton School of Business Pharmaceutical Executive Program。Patrick博士只将一部分时间用于我们的业务。Patrick博士为我们兼职工作。
- Jeff Patrick serves as Director of Drug Development Institute at the Ohio State University Comprehensive Cancer Center. Dr. Patrick most recently serving as Chief Scientific Officer for New Haven Pharmaceuticals. Prior roles included global vice president of professional affairs at Mallinckrodt Pharmaceuticals, Inc.; and roles with ascending responsibilities at Dyax, Myogen/Gilead, Actelion and Sanofi Synthelabo, Inc. Dr. Patrick is a residency trained clinical pharmacist with approximately 20 years of pharmaceutical indtry experience. Prior to pursuing a career in research and development, Patrick was an ambulatory care clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy, where he earned his doctorate in pharmacy.